Get to Market Now! Turn FDA Compliance into a Competitive Edge in the era of Personalized Medicine.
ADVERTISE HERE 

DrugPatentWatch Information on Approved Drugs and Drug Products

This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Drug Patent Expirations for July 2010

TradenameApplicantGeneric NamePatent Number Patent Expiration
PROAIR HFATeva Globalalbuterol sulfate5,695,743Jul 6, 2010
ISTODAXGloucester Pharmsromidepsin4,977,138Jul 6, 2010
ATROVENT HFABoehringer Ingelheimipratropium bromide5,695,743Jul 6, 2010
PROVENTIL-HFA3malbuterol sulfate5,439,670Jul 6, 2010
XOPENEX HFASepracorlevalbuterol tartrate5,439,670Jul 6, 2010
QVAR 40Teva Branded Pharmbeclomethasone dipropionate5,695,743Jul 6, 2010
ALVESCONycomed Usciclesonide5,695,743Jul 6, 2010
PROVENTIL-HFA3malbuterol sulfate5,225,183Jul 6, 2010
XOPENEX HFASepracorlevalbuterol tartrate5,225,183Jul 6, 2010
PROVENTIL-HFA3malbuterol sulfate5,695,743Jul 6, 2010
XOPENEX HFASepracorlevalbuterol tartrate5,695,743Jul 6, 2010
QVAR 80Teva Branded Pharmbeclomethasone dipropionate5,695,743Jul 6, 2010
AMERGEGlaxosmithklinenaratriptan hydrochloride4,997,841Jul 7, 2010
CLARINEXScheringdesloratadine5,178,878*PEDJul 12, 2010
TRELSTAR DEPOTWatson Labstriptorelin pamoate5,225,205Jul 20, 2010
DEFINITYLantheus Medclperflutren5,769,080Jul 20, 2010
TRELSTAR LAWatson Labstriptorelin pamoate5,225,205Jul 20, 2010
BETIMOLSanten Oytimolol5,231,095Jul 27, 2010
IMODIUM MULTI-SYMPTOM RELIEFMcneilloperamide hydrochloride; simethicone5,248,505Jul 28, 2010
ADVIL CONGESTION RELIEFWyeth Consibuprofen; phenylephrine hydrochloride5,087,454Jul 30, 2010

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.


Tentative Approvals

IngredientTentative Approvals
desloratadine1

*Tentative approvals are indicators of potential future generic entry. See the DrugPatentWatch database for complete details.

SUBSCRIPTIONS

If this newsletter has been forwarded to you and you would like to receive regular updates by email, go to http://www.DrugPatentWatch.com/newsletter

The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the DrugPatentWatch database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.

[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Affiliate Program | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]